Thant Ei Phway, Surachat Komwit, Chusri Sarunyou, Romyasamit Chonticha, Pomwised Rattanaruji, Wonglapsuwan Monwadee, Yaikhan Thunchanok, Suwannasin Sirikan, Singkhamanan Kamonnut
Department of Biomedical Sciences and Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.
Translational Medicine Research Center, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.
Antibiotics (Basel). 2024 Jun 28;13(7):604. doi: 10.3390/antibiotics13070604.
Growing interest in probiotics has spurred research into their health benefits for hosts. This study aimed to evaluate the probiotic properties, especially antibacterial activities and the safety of two strains, W1 and W2, isolated from Khao-Mahk by describing their phenotypes and genotypes through phenotypic assays and whole genome sequencing. In vitro experiments demonstrated that both strains exhibited robust survival under gastric and intestinal conditions, such as in the presence of low pH, bile salt, pepsin, and pancreatin, indicating their favorable gut colonization traits. Additionally, both strains showed auto-aggregation and strong adherence to Caco2 cells, with adhesion rates of 86.86 ± 1.94% for W1 and 94.74 ± 2.29% for W2. These high adherence rates may be attributed to the significant exopolysaccharide (EPS) production observed in both strains. Moreover, they exerted remarkable antimicrobial activities against , serotype Typhi, , and , along with an absence of hemolytic activities and antibiotic resistance, underscoring their safety for probiotic application. Genomic analysis corroborated these findings, revealing genes related to probiotic traits, including EPS clusters, stress responses, adaptive immunity, and antimicrobial activity. Importantly, no transferable antibiotic-resistance genes or virulence genes were detected. This comprehensive characterization supports the candidacy of W1 and W2 as probiotics, offering substantial potential for promoting health and combating bacterial infections.
人们对益生菌的兴趣日益浓厚,这激发了对其对宿主健康益处的研究。本研究旨在通过表型分析和全基因组测序来描述从考马赫分离出的两株菌株W1和W2的表型和基因型,从而评估它们的益生菌特性,尤其是抗菌活性和安全性。体外实验表明,两株菌株在胃和肠道条件下,如在低pH值、胆盐、胃蛋白酶和胰蛋白酶存在的情况下,均表现出强大的生存能力,表明它们具有良好的肠道定植特性。此外,两株菌株均表现出自动聚集以及对Caco2细胞的强烈粘附,W1的粘附率为86.86±1.94%,W2的粘附率为94.74±2.29%。这些高粘附率可能归因于在两株菌株中均观察到的显著胞外多糖(EPS)产生。此外,它们对伤寒杆菌、大肠杆菌和金黄色葡萄球菌具有显著的抗菌活性,同时不存在溶血活性和抗生素耐药性,这突出了它们在益生菌应用中的安全性。基因组分析证实了这些发现,揭示了与益生菌特性相关的基因,包括EPS簇、应激反应、适应性免疫和抗菌活性。重要的是,未检测到可转移的抗生素耐药基因或毒力基因。这种全面的表征支持了W1和W2作为益生菌的候选资格,为促进健康和对抗细菌感染提供了巨大潜力。